| The New York Times 2005 Alex Berenson |
| Title | Subject | Authors |
|---|
| 10 Voters on Panel Backing Pain Pills Had Industry Ties.(National Desk) | News, opinion and commentary | Alex Berenson, Gardiner Harris |
| A Lawyer's Stock Rises With Victory Over Merck.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| A Reminder That No Drug Is Risk-Free.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson, Barnaby Feder |
| At Pfizer, the Isolation Increases for a Whistle-Blower.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| At Vioxx Trial, a Discrepancy Appears to Undercut Merck's Defense.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| Jurors in the Vioxx Trial Hear Closing Arguments.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| Jury Begins To Deliberate Vioxx Case.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| Lilly to Pay $690 Million In Drug Suits.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| Lipitor or Generic? Billion-Dollar Battle Looms.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| Merck Asks Court to Dismiss First Vioxx Suit.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| Pfizer Says 1999 Trials Revealed Risks With Celebrex.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson, Gardiner Harris |
| Some Analysts Expect Job Cuts From Pfizer.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
| Vision Loss Is Reported In a Few Users Of Viagra.(Business/Financial Desk) | News, opinion and commentary | Alex Berenson, Jennifer Bayot |
| Where Has All the Prilosec Gone?(Business/Financial Desk) | News, opinion and commentary | Alex Berenson |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
